Abstract Aims To explore the changes in bone mineral density (BMD) and body composition in patients after bariatric surgery using dual‐energy X‐ray absorptiometry (DXA) and quantitative computed tomography (QCT), analyse the relationships between these changes and weight loss, and the correlations between the parameters of DXA and QCT.
Xiaoqing Yuan+10 more
wiley +1 more source
Success Rate and Factors Associated With Surveillance Endoscopy After Proximal Gastrectomy With Double-Tract Reconstruction: A Retrospective Multicenter Cohort Study. [PDF]
Seo JW, Park KB.
europepmc +1 more source
ASO Author Reflections: Future of Reporting Complications After Gastric Cancer Surgery. [PDF]
Putila E+3 more
europepmc +1 more source
Medical Aspects of the Holy Eucharist: A Physiological and Canonical Study [PDF]
Casey, Thomas F., Laforet, Eugene G.
core +1 more source
Cholecystokinin: Clinical aspects of the new biology
Abstract Cholecystokinin (CCK) is a classic gut hormone that has been known for almost a century to regulate gallbladder emptying, pancreatic enzyme secretion, and gastrointestinal motor activity. In 1968, the CCK structure was identified by Viktor Mutt and Erik Jorpes from porcine gut extracts as a peptide of 33 amino acid residues.
Jens F. Rehfeld
wiley +1 more source
Successful biliary cannulation in complex anatomy: effectiveness of a novel rotatable sphincterotome in a case of billroth-I gastrectomy and periampullary diverticulum. [PDF]
Kondo S, Kuraishi Y, Nakamura A.
europepmc +1 more source
Abstract Background Gastric cancer peritoneal metastasis is clinically challenging, given the limited treatment options and poor prognosis. The molecular mechanisms that precede gastric cancer peritoneal metastasis, known as the pre‐metastatic niche (PMN), and its relationship with N6‐methyladenosine (m6A) modification remain unclear.
Song Li+23 more
wiley +1 more source
Nutritional and Biochemical Outcomes After Total Versus Subtotal Gastrectomy: Insights into Early Postoperative Prognosis. [PDF]
Akad F+11 more
europepmc +1 more source
Efficacy and Safety of a 3‐Weekly TS‐1 Adjuvant Regimen in Advanced Gastric Cancer: A Pilot Study
ABSTRACT Background TS‐1 at 80 mg/m2/day for 4 weeks followed by a 2‐week rest is standard adjuvant therapy for stage II/III Advanced Gastric Cancer (AGC). TS‐1 for 1 year (8 courses) is highly recommended. We investigated the efficacy and safety of an adjuvant 3‐weekly TS‐1 regimen for AGC.
Jihong Bae+9 more
wiley +1 more source